Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense RNA therapy for CML--an hypothesis.

K S Nadkarni1, R H Datar, S G Rao

  • 1Tata Memorial Hospital, Bombay, India.

Medical Hypotheses
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antisense molecular biology.

The National medical journal of India·2018
Same author

Transglutaminase-2 regulation by arecoline in gingival fibroblasts.

Journal of dental research·2009
Same author

New spectrophotometric method for the determination of some drugs with iodine and wool fast blue BL.

Talanta·2008
Same author

Obesity and obstetric anaesthesia.

Anaesthesia·2006
Same author

Successful management of isolated ventricular inversion in an adult.

Pediatric cardiology·2004
Same author

Stem cells and their therapeutic potential.

Indian journal of experimental biology·2002
Same journal

Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

Medical hypotheses·2026
Same journal

Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

Medical hypotheses·2025
Same journal

The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

Medical hypotheses·2025
Same journal

Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

Medical hypotheses·2025
Same journal

How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

Medical hypotheses·2024
Same journal

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
See all related articles

Gene therapy offers a potential cure for chronic myeloid leukemia (CML) by targeting the bcr-c-abl fusion gene. This approach involves antisense RNA to block the abnormal gene, aiming for a 100% remission rate.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the Philadelphia chromosome (ph'), resulting from a bcr-c-abl fusion gene.
  • Current treatments like chemotherapy and bone marrow transplantation (BMT) often fail to achieve long-term remission or cure.

Purpose of the Study:

  • To explore gene therapy as an alternative treatment for CML by targeting the genetic defect.
  • To investigate the potential of antisense RNA therapy to block the expression of the bcr-c-abl fusion gene.

Main Methods:

  • Proposed method involves autologous bone marrow transplantation after genetic modification.
  • Myeloid stem cells would be engineered to constitutively express antisense RNA targeting bcr-c-abl mRNA.

Related Experiment Videos

  • Engineered stem cells would be reinfused into the patient.

    • Main Results:

    • Antisense RNA therapy could correct the genetic defect responsible for CML.
    • This approach may offer advantages over current treatments, including no graft rejection.
    • Potential for achieving 100% remission in CML patients.

    Conclusions:

    • Gene therapy, specifically antisense RNA targeting the bcr-c-abl fusion gene, presents a promising alternative for CML treatment.
    • This strategy could overcome limitations of current therapies and potentially lead to a cure.